Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy
In this interview from SfN 2024, Professor Nancy Ip, President of The Hong Kong University of Science and Technology, shares ...
Tag: Microglia
The molecular underpinnings by which traumatic brain injury increases Alzheimer's disease risk
Researchers found that traumatic brain injury increases synaptic dysfunction and cognitive impairments linked to developing Alzheimer's disease. Study: Neuronal BAG3 ...
Study finds Plexin-B1 could be key to Alzheimer’s treatment, enhancing glial cell response
A recent study published in the journal Nature Neuroscience revealed that Plexin-B1, encoded by PLXNB1, regulates the activation of peri-plaque ...
Unlocking glioblastoma's immune suppression mechanism
The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma -; a ...
PET brain scans could reveal hidden inflammation in patients with multiple sclerosis
A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests positron emission tomography (PET) ...
Researchers find a promising approach to remove amyloid plaques in Alzheimer's disease
Alzheimer's disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off ...
Unlocking Alzheimer's secrets: Study pinpoints APOE4's harmful effect on lipids
UNC School of Medicine researcher Sarah Cohen, PhD, and Ian Windham, a former PhD student from the Cohen lab, have ...
Microglia found to play a key role in regulating the body's response to anesthesia
Though it may be a surprise to the millions of people who undergo general anesthesia every year for medical procedures, ...
Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress
In a recent study published in the journal Scientific Reports, researchers examined the use of curcumin as an adjuvant to ...
Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal
Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug ...
